The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / M•••••• R••••• I•••••••• o• A••••••

M•••••• R••••• I•••••••• o• A•••••• Announces S•••••••• Growth Investment

Exit to a strategic buyerannouncedannounced Jul 8, 2024Fact
What happened
Target
M•••••• R••••• I•••••••• o• A••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / medical
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • S••••••••Strategic acquirerconfirmed
    “M•••••• R••••• I•••••••• o• A•••••• Announces S•••••••• Growth Investment”
Sell side
  • S••••• P•••••••• L•••Sellerconfirmed
    “As part of the transaction, MRIoA management and existing investor S••••• Partners will both retain significant equity ownership in the business. | published on S••••• Partners's own news page www.summitpartners.com”
Side not stated
Evidence
“M•••••• R••••• I•••••••• o• A•••••• Announces S•••••••• Growth Investment”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 14, 2026
M•••••• R••••• I•••••••• o• A•••••• Announces S•••••••• Growth Investment | Private Equity Intelligence | DFX